• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

NIH resumes critical grant-making process after federal communications freeze at HHS

by February 7, 2025
written by February 7, 2025

The National Institutes of Health (NIH) will resume important meetings and travel associated with the critical grant-review process amid an agency-wide communications freeze at the Department of Health and Human Services (HHS).

While the agency is working its way back to normalcy, its operations are still not completely back to what they were before President Donald Trump took office. The advisory council and scientific review meetings associated with the NIH’s grant-making process, in which outside scientists provide a final grant review and strategic advice before the finalization of a new program, have continued but will not yet meet in open session.  

When Trump took office, he initiated a freeze on external communications at HHS and all of its sub-agencies. Earlier this week, HHS spokesman Andrew Nixon said that ‘several types of external communications’ are no longer subject to the pause, and ‘all HHS divisions have been given clear guidance on how to seek approval for any other type of mass communication.’

NIH is currently taking things day-by-day to ensure they are meeting their obligations under the Federal Advisory Committee Act, which governs the operation of federal advisory committees and emphasizes public involvement through open meetings and reporting.

Last week, NIH director Matthew Memoli sent a letter to staff seeking to clarify the ongoing communications pause. According to Memoli, the freeze had been issued to ‘allow the new team to set up a process for review and prioritization,’ but noted that due to ‘confusion on the scope of the pause’ he wanted to provide additional guidance.

In addition to halting announcements, press releases, website and social media posts, new guidance, and new regulations, the freeze also halted public appearances and travel by agency officials, and prohibited new purchases or service requests related to agency work. The move caused anger and confusion among both HHS officials and those in the broader medical community, particularly due to the potential pause of critical health research.

In his memo to staff, Memoli clarified that any research or clinical trials initiated before Jan. 20 can keep going ‘so that this work can continue, and we do not lose our investment in these studies.’ Officials working on these studies may also purchase any ‘necessary supplies’ and conduct meetings related to such work. Although new research projects are still prohibited, NIH staff were told they could continue submitting papers to medical journals and can communicate with those journals about submitted work.

Travel and hiring for such work can continue as well, Memoli indicated, but his office must grant specific exemptions for new hires as Trump also initiated a freeze on the hiring of new federal civilian employees across all agencies during his first week in office. Routine travel planned for after Feb. 1 ‘does not need to be canceled at this time,’ Memoli added. Patients receiving treatment at NIH facilities can also continue to do so. 

NIH can also submit documents to the Federal Register and send correspondence to public officials.

While the pause at HHS has caused a firestorm of concern and criticism, Dr. Ali Khan, a former Centers for Disease Control and Prevention scientist who is now the dean of the University of Nebraska’s school of public health, told the Associated Press that such pauses are not unusual. Khan said concern is only warranted if the pause was aimed at ‘silencing the agencies around a political narrative.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
The Hitchhiker’s Guide to House Republicans releasing their tax and spending cut plan
next post
FBI agents’ association ‘optimistic’ about AG Bondi despite early controversy with Trump administration

related articles

Federal judge to sentence Justice Brett Kavanaugh’s attempted...

October 3, 2025

Hawley blasts FDA approval of new abortion drug,...

October 2, 2025

Trump’s DOGE savings dwarfed by Medicare, Social Security...

October 2, 2025

FLASHBACK: James Comey urged officials to always prosecute...

October 2, 2025

The agency staff Vought might recommend cutting and...

October 2, 2025

Reagan-appointed judge, once rebuked by Supreme Court, continues...

October 2, 2025

‘Real consequences’: Food aid, flood insurance, FEMA funds...

October 2, 2025

Trump must triple severely outdated nuke arsenal to...

October 2, 2025

White House says federal layoffs could hit ‘thousands’...

October 2, 2025

Johnson shuts door on negotiating shutdown deal as...

October 2, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump envoy for Russia and Ukraine calls Zelenskyy a ‘courageous leader’ after Trump lambasts foreign figure

    February 21, 2025
  • USAID activists say stopping ‘corporate welfare’ outweighs ending funds to terror-linked groups

    February 5, 2025
  • Medvedev warns Trump’s new deadline to end Russia-Ukraine conflict is a ‘step towards war’

    July 29, 2025
  • Supreme Court hands Ed Sheeran legal win in Marvin Gaye copyright fight

    June 16, 2025
  • Trump previously predicted Biden would pardon son Hunter

    December 2, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,248)
  • Investing (634)
  • Stock (935)

Latest Posts

  • Johnson pushes ‘aggressive’ timetable for House to pass Trump’s budget bill after GOP mutiny: ‘We cannot fail’

    May 18, 2025
  • ‘Master dealmaker’: Inside Trump’s budget bill victory amid House GOP rebellion

    February 27, 2025
  • Hamas reacts to Trump victory, says he must ‘work seriously to stop the war’ in Gaza

    November 6, 2024

Recent Posts

  • LVMH drops 8% on sales miss as geopolitics hit wine, fashion revenues; Kering, Burberry fall too

    April 15, 2025
  • Number of injunctions halting Trump policies trounces predecessors by double

    March 17, 2025
  • ‘Death of DEI’: GOP senator expected to take victory lap against ‘wokeness’ in CPAC speech

    February 20, 2025

Editor’s Pick

  • Task force to expose ‘federal secrets’ on JFK assassination, Epstein, UFOs packed with GOP rebels

    February 18, 2025
  • ‘Fully justified’: Graham plows ahead with Trump border funding despite Paul’s objections

    June 12, 2025
  • Republican senator claims RFK Jr. mRNA vaccine decision undermines Trump agenda

    August 7, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock